Lung tumor development in mice exposed to tobacco smoke and fed β-carotene diets

Ute C. Obermueller-Jevic, Imelda Espiritu, Ana M. Corbacho, Carroll E Cross, Hanspeter Witschi

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

In human clinical trials it was found that the putative chemopreventive agent β-carotene not only failed to protect active smokers against the carcinogenic action of tobacco smoke, but actually increased their risk of developing lung cancer. In preclinical animal studies, β-carotene had been effective against some chemically induced cancers, but not against tumors in the respiratory tract. We exposed male strain A/J mice to tobacco smoke at a concentration of 140 mg/m3 of total suspended particulate matter, 6 h a day, 5 days a week, for either 4 or 5 months, followed by a recovery period in air for 4 or 5 months, or for 9 months without recovery period. β-carotene was added in the form of gelatin beadlets to the AIN-93G diet either during or following tobacco smoke exposure at concentrations of 0.005, 0.05 and 0.5%. In the supplement-fed animals, plasma and lung levels of β-carotene were higher than they were in animals fed control diets. Exposure to tobacco smoke increased rather than decreased plasma β-carotene levels, but had no significant effect on lung levels. After 9 months, lung tumor multiplicities and incidence were determined. Tobacco smoke increased both lung tumor multiplicities and incidences, but β-carotene failed to modulate tumor development under all exposure conditions. Animal studies in a model of tobacco smoke carcinogenesis would thus have predicted the absence of any beneficial effects of β-carotene supplementation in current or former smokers, but would have failed to anticipate the increase in lung cancer risk.

Original languageEnglish (US)
Pages (from-to)23-29
Number of pages7
JournalToxicological Sciences
Volume69
Issue number1
DOIs
StatePublished - Sep 2002

Fingerprint

Tobacco
Carotenoids
Nutrition
Smoke
Tumors
Diet
Lung
Animals
Neoplasms
Lung Neoplasms
Plasmas
Recovery
Particulate Matter
Incidence
Gelatin
Respiratory System
Carcinogenesis
Air
Clinical Trials

Keywords

  • β-carotene
  • Chemoprevention
  • Cigarette smoke
  • Lung tumors
  • Strain A mice

ASJC Scopus subject areas

  • Toxicology

Cite this

Lung tumor development in mice exposed to tobacco smoke and fed β-carotene diets. / Obermueller-Jevic, Ute C.; Espiritu, Imelda; Corbacho, Ana M.; Cross, Carroll E; Witschi, Hanspeter.

In: Toxicological Sciences, Vol. 69, No. 1, 09.2002, p. 23-29.

Research output: Contribution to journalArticle

Obermueller-Jevic, Ute C. ; Espiritu, Imelda ; Corbacho, Ana M. ; Cross, Carroll E ; Witschi, Hanspeter. / Lung tumor development in mice exposed to tobacco smoke and fed β-carotene diets. In: Toxicological Sciences. 2002 ; Vol. 69, No. 1. pp. 23-29.
@article{7b3c24e1a6044435830186fccaade460,
title = "Lung tumor development in mice exposed to tobacco smoke and fed β-carotene diets",
abstract = "In human clinical trials it was found that the putative chemopreventive agent β-carotene not only failed to protect active smokers against the carcinogenic action of tobacco smoke, but actually increased their risk of developing lung cancer. In preclinical animal studies, β-carotene had been effective against some chemically induced cancers, but not against tumors in the respiratory tract. We exposed male strain A/J mice to tobacco smoke at a concentration of 140 mg/m3 of total suspended particulate matter, 6 h a day, 5 days a week, for either 4 or 5 months, followed by a recovery period in air for 4 or 5 months, or for 9 months without recovery period. β-carotene was added in the form of gelatin beadlets to the AIN-93G diet either during or following tobacco smoke exposure at concentrations of 0.005, 0.05 and 0.5{\%}. In the supplement-fed animals, plasma and lung levels of β-carotene were higher than they were in animals fed control diets. Exposure to tobacco smoke increased rather than decreased plasma β-carotene levels, but had no significant effect on lung levels. After 9 months, lung tumor multiplicities and incidence were determined. Tobacco smoke increased both lung tumor multiplicities and incidences, but β-carotene failed to modulate tumor development under all exposure conditions. Animal studies in a model of tobacco smoke carcinogenesis would thus have predicted the absence of any beneficial effects of β-carotene supplementation in current or former smokers, but would have failed to anticipate the increase in lung cancer risk.",
keywords = "β-carotene, Chemoprevention, Cigarette smoke, Lung tumors, Strain A mice",
author = "Obermueller-Jevic, {Ute C.} and Imelda Espiritu and Corbacho, {Ana M.} and Cross, {Carroll E} and Hanspeter Witschi",
year = "2002",
month = "9",
doi = "10.1093/toxsci/69.1.23",
language = "English (US)",
volume = "69",
pages = "23--29",
journal = "Toxicological Sciences",
issn = "1096-6080",
publisher = "Oxford University Press",
number = "1",

}

TY - JOUR

T1 - Lung tumor development in mice exposed to tobacco smoke and fed β-carotene diets

AU - Obermueller-Jevic, Ute C.

AU - Espiritu, Imelda

AU - Corbacho, Ana M.

AU - Cross, Carroll E

AU - Witschi, Hanspeter

PY - 2002/9

Y1 - 2002/9

N2 - In human clinical trials it was found that the putative chemopreventive agent β-carotene not only failed to protect active smokers against the carcinogenic action of tobacco smoke, but actually increased their risk of developing lung cancer. In preclinical animal studies, β-carotene had been effective against some chemically induced cancers, but not against tumors in the respiratory tract. We exposed male strain A/J mice to tobacco smoke at a concentration of 140 mg/m3 of total suspended particulate matter, 6 h a day, 5 days a week, for either 4 or 5 months, followed by a recovery period in air for 4 or 5 months, or for 9 months without recovery period. β-carotene was added in the form of gelatin beadlets to the AIN-93G diet either during or following tobacco smoke exposure at concentrations of 0.005, 0.05 and 0.5%. In the supplement-fed animals, plasma and lung levels of β-carotene were higher than they were in animals fed control diets. Exposure to tobacco smoke increased rather than decreased plasma β-carotene levels, but had no significant effect on lung levels. After 9 months, lung tumor multiplicities and incidence were determined. Tobacco smoke increased both lung tumor multiplicities and incidences, but β-carotene failed to modulate tumor development under all exposure conditions. Animal studies in a model of tobacco smoke carcinogenesis would thus have predicted the absence of any beneficial effects of β-carotene supplementation in current or former smokers, but would have failed to anticipate the increase in lung cancer risk.

AB - In human clinical trials it was found that the putative chemopreventive agent β-carotene not only failed to protect active smokers against the carcinogenic action of tobacco smoke, but actually increased their risk of developing lung cancer. In preclinical animal studies, β-carotene had been effective against some chemically induced cancers, but not against tumors in the respiratory tract. We exposed male strain A/J mice to tobacco smoke at a concentration of 140 mg/m3 of total suspended particulate matter, 6 h a day, 5 days a week, for either 4 or 5 months, followed by a recovery period in air for 4 or 5 months, or for 9 months without recovery period. β-carotene was added in the form of gelatin beadlets to the AIN-93G diet either during or following tobacco smoke exposure at concentrations of 0.005, 0.05 and 0.5%. In the supplement-fed animals, plasma and lung levels of β-carotene were higher than they were in animals fed control diets. Exposure to tobacco smoke increased rather than decreased plasma β-carotene levels, but had no significant effect on lung levels. After 9 months, lung tumor multiplicities and incidence were determined. Tobacco smoke increased both lung tumor multiplicities and incidences, but β-carotene failed to modulate tumor development under all exposure conditions. Animal studies in a model of tobacco smoke carcinogenesis would thus have predicted the absence of any beneficial effects of β-carotene supplementation in current or former smokers, but would have failed to anticipate the increase in lung cancer risk.

KW - β-carotene

KW - Chemoprevention

KW - Cigarette smoke

KW - Lung tumors

KW - Strain A mice

UR - http://www.scopus.com/inward/record.url?scp=0036738720&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036738720&partnerID=8YFLogxK

U2 - 10.1093/toxsci/69.1.23

DO - 10.1093/toxsci/69.1.23

M3 - Article

VL - 69

SP - 23

EP - 29

JO - Toxicological Sciences

JF - Toxicological Sciences

SN - 1096-6080

IS - 1

ER -